Bryan Smith Selected Research

Bryan Smith Research Topics

Disease

13	Malaria 01/2019 - 12/2010
6	Heart Failure 05/2020 - 01/2019
4	Stroke (Strokes) 01/2022 - 05/2013
4	Falciparum Malaria (Plasmodium falciparum Malaria) 07/2014 - 12/2010
3	Body Weight (Weight, Body) 01/2019 - 11/2012
3	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 11/2017
3	Infections 11/2017 - 10/2016
2	Fatigue 02/2024 - 01/2024
2	Hemorrhage 01/2022 - 10/2018
2	Multiple Sclerosis 01/2022 - 02/2019
2	Nausea 01/2022 - 05/2017
2	Thrombosis (Thrombus) 04/2020 - 01/2020
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2019 - 10/2018
2	Parasitemia 01/2019 - 11/2012
2	Myasthenia Gravis 10/2018 - 11/2016
2	Asthma (Bronchial Asthma) 01/2018 - 01/2013
1	Babesiosis (Piroplasmosis) 05/2024
1	Amyloidosis 03/2024
1	Cardiomyopathies (Cardiomyopathy) 03/2024
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2022
1	Demyelinating Diseases (Demyelinating Disease) 01/2022
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2022
1	Neuromyelitis Optica (Devic's Disease) 01/2022
1	Primary Graft Dysfunction 01/2022
1	Hearing Loss (Hearing Impairment) 04/2021
1	Diseases Newborn Infant 01/2021
1	Arthrogryposis 01/2021
1	Congenital Abnormalities (Deformity) 01/2021
1	Neoplasms (Cancer) 12/2020
1	Pemphigus (Pemphigus Vulgaris) 01/2020
1	Right Ventricular Dysfunction 01/2020
1	Hyponatremia 01/2020
1	Hypernatremia 01/2020
1	Systolic Heart Failure 01/2020
1	Epidermolysis Bullosa Acquisita (Acquired Epidermolysis Bullosa) 01/2020
1	Bullous Pemphigoid (Pemphigoid) 01/2020
1	Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve) 12/2019
1	Insulin Resistance 11/2019
1	Neuroinflammatory Diseases 02/2019
1	Tropical Spastic Paraparesis (Tropical Spastic Paraplegia) 02/2019
1	Hyperbilirubinemia 01/2019
1	Progressive Multifocal Leukoencephalopathy 01/2019
1	Hemolysis 01/2019
1	Inflammation (Inflammations) 10/2018
1	Sudden Death 12/2017
1	Gastroenteritis 05/2017
1	Vomiting 05/2017
1	Neck Pain (Cervicalgia) 05/2017
1	Diarrhea 05/2017

Drug/Important Bio-Agent (IBA)

9	tafenoquineIBA 05/2024 - 02/2014
7	ArtesunateIBA 01/2019 - 12/2010
6	Immunoglobulin G (IgG)IBA 01/2022 - 11/2017
4	AntibodiesIBA 01/2021 - 11/2016
4	AutoantibodiesIBA 01/2020 - 11/2016
4	Antimalarials (Antimalarial Agents)IBA 01/2019 - 02/2014
3	Proteins (Proteins, Gene)FDA Link 03/2024 - 02/2019
3	neonatal Fc receptorIBA 01/2021 - 11/2017
3	artemisinin (artemisinine)IBA 01/2019 - 01/2011
3	Mefloquine (Lariam)FDA LinkGeneric 11/2015 - 09/2011
3	Primaquine FDA Link 11/2015 - 02/2014
2	Monoclonal AntibodiesIBA 01/2021 - 01/2018
2	Hemoglobins (Hemoglobin)IBA 11/2019 - 01/2019
2	Quinine (Quinson)FDA Link 01/2019 - 12/2010
2	rozanolixizumabIBA 10/2018 - 11/2017
2	AllergensIBA 01/2018 - 01/2013
1	Azithromycin (Zithromax)FDA LinkGeneric 05/2024
1	Atovaquone (Mepron)FDA Link 05/2024
1	catechol (pyrocatechol)IBA 02/2024
1	Biomarkers (Surrogate Marker)IBA 01/2024
1	Myelin-Oligodendrocyte GlycoproteinIBA 01/2022
1	Luxol Fast Blue MBS (Luxol fast blue)IBA 01/2022
1	EpitopesIBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	Fc Receptors (Fc Receptor)IBA 01/2022
1	Oligoclonal BandsIBA 04/2021
1	Cholinergic ReceptorsIBA 01/2021
1	Phosphotransferases (Kinase)IBA 12/2020
1	SodiumIBA 01/2020
1	Therapeutic UsesIBA 01/2020
1	Tolvaptan FDA Link 01/2020
1	Testosterone (Sustanon)FDA Link 11/2019
1	butyl phosphorotrithioate (DEF)IBA 02/2019
1	Protons (Proton)IBA 02/2019
1	pembrolizumabIBA 01/2019
1	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 01/2019
1	Inosine Triphosphate (ITP)IBA 01/2019
1	Lumefantrine Drug Combination Artemether (Coartem)FDA Link 01/2019
1	Immunoglobulin FragmentsIBA 01/2018
1	Immunoglobulin Fab FragmentsIBA 01/2018
1	CytokinesIBA 01/2018
1	Interleukin-13IBA 01/2018

Therapy/Procedure

13	Therapeutics 04/2020 - 12/2009
9	Heart-Assist Devices 05/2020 - 10/2018
1	Extracorporeal Membrane Oxygenation 01/2022
1	Transplantation 01/2021
1	Heart Transplantation (Grafting, Heart) 01/2021
1	Cannula 01/2020
1	Chemoprevention 01/2019
1	Patient Readmission 01/2019
1	Secondary Prevention 12/2017